Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?

Identifieur interne : 009E85 ( Main/Exploration ); précédent : 009E84; suivant : 009E86

Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?

Auteurs : Wen C. Liang [États-Unis] ; Brenda J. Sickle-Santanello [États-Unis] ; Thomas A. Nims [États-Unis]

Source :

RBID : ISTEX:B41ADE4EF645AACD2CE7AF24F945818B3BC08751

English descriptors

Abstract

Objective: The purpose of this study is to determine if a completion axillary dissection (CAD) is necessary when microscopic metastasis (<2 mm) is detected in the sentinel lymph node (SLN) of patients diagnosed with breast cancer.Methods: A retrospective chart review was performed on 227 consecutive breast cancer patients who underwent SLN mapping (SLNM) between June 1998 and March 2001. These patients underwent intraoperative lymphatic mapping with peritumoral injections of blue dye alone or in combination with technetium-labeled sulfur colloid. The SLN was assessed by touch preparation or frozen section at the time of surgery, and later, by hematoxylin and eosin stain. Patients in whom the SLN showed evidence of metastatic disease on frozen section underwent immediate CAD.Results: One patient was excluded because of inability to identify the SLN. Of the 226 patients in whom SLNM was successful, 67 (27%) had macrometastasis in the SLN, and a completion CAD was performed. Thirty-four of these 67 patients (51%) had additional disease in the axilla. A total of 15 patients (6.7%) was determined to have micrometastasis. In 11 patients, micrometastasis was identified and CAD was performed with no further evidence of disease. The 4 patients diagnosed with micrometastatic disease on permanent staining did not have further surgical intervention. The 15 patients identified with micrometastasis show no evidence of local recurrence to date, with a mean follow-up of 13.5 months (range 1 to 27).Conclusions: This study suggests that CAD may not be necessary for the subset of breast cancer patients with micrometastasis detected upon SLNM. A larger randomized prospective study with long-term follow up is necessary to confirm these data.

Url:
DOI: 10.1016/S0002-9610(01)00738-3


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?</title>
<author>
<name sortKey="Liang, Wen C" sort="Liang, Wen C" uniqKey="Liang W" first="Wen C" last="Liang">Wen C. Liang</name>
</author>
<author>
<name sortKey="Sickle Santanello, Brenda J" sort="Sickle Santanello, Brenda J" uniqKey="Sickle Santanello B" first="Brenda J" last="Sickle-Santanello">Brenda J. Sickle-Santanello</name>
</author>
<author>
<name sortKey="Nims, Thomas A" sort="Nims, Thomas A" uniqKey="Nims T" first="Thomas A" last="Nims">Thomas A. Nims</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B41ADE4EF645AACD2CE7AF24F945818B3BC08751</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0002-9610(01)00738-3</idno>
<idno type="url">https://api.istex.fr/document/B41ADE4EF645AACD2CE7AF24F945818B3BC08751/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">005464</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005464</idno>
<idno type="wicri:Area/Istex/Curation">005464</idno>
<idno type="wicri:Area/Istex/Checkpoint">002B88</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002B88</idno>
<idno type="wicri:doubleKey">0002-9610:2001:Liang W:is:a:completion</idno>
<idno type="wicri:Area/Main/Merge">00A338</idno>
<idno type="wicri:Area/Main/Curation">009E85</idno>
<idno type="wicri:Area/Main/Exploration">009E85</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?</title>
<author>
<name sortKey="Liang, Wen C" sort="Liang, Wen C" uniqKey="Liang W" first="Wen C" last="Liang">Wen C. Liang</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgical Oncology, Grant Medical Center, Suite 911, Baldwin Tower, 300 E. Town Street, Columbus, OH 43215</wicri:regionArea>
<placeName>
<region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sickle Santanello, Brenda J" sort="Sickle Santanello, Brenda J" uniqKey="Sickle Santanello B" first="Brenda J" last="Sickle-Santanello">Brenda J. Sickle-Santanello</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgical Oncology, Grant Medical Center, Suite 911, Baldwin Tower, 300 E. Town Street, Columbus, OH 43215</wicri:regionArea>
<placeName>
<region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nims, Thomas A" sort="Nims, Thomas A" uniqKey="Nims T" first="Thomas A" last="Nims">Thomas A. Nims</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgical Oncology, Grant Medical Center, Suite 911, Baldwin Tower, 300 E. Town Street, Columbus, OH 43215</wicri:regionArea>
<placeName>
<region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The American Journal of Surgery</title>
<title level="j" type="abbrev">AJS</title>
<idno type="ISSN">0002-9610</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">182</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="365">365</biblScope>
<biblScope unit="page" to="368">368</biblScope>
</imprint>
<idno type="ISSN">0002-9610</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0002-9610</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Completion axillary dissection</term>
<term>Micrometastases</term>
<term>Sentinel lymph node</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Objective: The purpose of this study is to determine if a completion axillary dissection (CAD) is necessary when microscopic metastasis (<2 mm) is detected in the sentinel lymph node (SLN) of patients diagnosed with breast cancer.Methods: A retrospective chart review was performed on 227 consecutive breast cancer patients who underwent SLN mapping (SLNM) between June 1998 and March 2001. These patients underwent intraoperative lymphatic mapping with peritumoral injections of blue dye alone or in combination with technetium-labeled sulfur colloid. The SLN was assessed by touch preparation or frozen section at the time of surgery, and later, by hematoxylin and eosin stain. Patients in whom the SLN showed evidence of metastatic disease on frozen section underwent immediate CAD.Results: One patient was excluded because of inability to identify the SLN. Of the 226 patients in whom SLNM was successful, 67 (27%) had macrometastasis in the SLN, and a completion CAD was performed. Thirty-four of these 67 patients (51%) had additional disease in the axilla. A total of 15 patients (6.7%) was determined to have micrometastasis. In 11 patients, micrometastasis was identified and CAD was performed with no further evidence of disease. The 4 patients diagnosed with micrometastatic disease on permanent staining did not have further surgical intervention. The 15 patients identified with micrometastasis show no evidence of local recurrence to date, with a mean follow-up of 13.5 months (range 1 to 27).Conclusions: This study suggests that CAD may not be necessary for the subset of breast cancer patients with micrometastasis detected upon SLNM. A larger randomized prospective study with long-term follow up is necessary to confirm these data.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Ohio</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Ohio">
<name sortKey="Liang, Wen C" sort="Liang, Wen C" uniqKey="Liang W" first="Wen C" last="Liang">Wen C. Liang</name>
</region>
<name sortKey="Nims, Thomas A" sort="Nims, Thomas A" uniqKey="Nims T" first="Thomas A" last="Nims">Thomas A. Nims</name>
<name sortKey="Sickle Santanello, Brenda J" sort="Sickle Santanello, Brenda J" uniqKey="Sickle Santanello B" first="Brenda J" last="Sickle-Santanello">Brenda J. Sickle-Santanello</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009E85 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009E85 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B41ADE4EF645AACD2CE7AF24F945818B3BC08751
   |texte=   Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node?
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024